Skip to main content

After a Decade of Decline, India’s Out-of-Pocket Health Bill Turns Upward

For the first time in 10 years, the share of India’s health bill that families pay out of pocket has begun to climb again. Here is what the latest official numbers say, and what they mean for the household standing at the billing counter.

When a family in Tatanagar, in Jharkhand, learned that the father had prostate cancer that had spread to his bones, they did what many Indian families do: find money however they could. Over two years of treatment at the Tata Memorial Hospital in Mumbai, they spent more than INR 700,000. To arrange these funds, they sold all their gold, including the gold set aside for a daughter’s wedding, and then sold a plot of land worth around INR 900,000 for only INR 200,000 because they needed money at once. By the time the treatment ended, the father’s small business had collapsed during the Covid-19 lockdown, and he was left almost penniless. Accounts like this one, which IndiaSpend reported, are not rare.

The part of that bill that no scheme and no insurer agreed to cover has a name. Health economists call it out-of-pocket expenditure (OOPE), the money paid directly for consultations, medicines, diagnostic tests and hospital charges. It is one of the clearest measures of how heavily a health system leans on the people who use it. For most of the last decade, this share had been falling, and its fall was one of the quieter achievements of Indian health policy. The latest official accounts suggest that the direction has now turned.

The tenth National Health Accounts (NHA) report, prepared by the Ministry of Health and Family Welfare (MoHFW) for the year 2022-23, records OOPE at 43.4 per cent of total health spending, up from 39.4 per cent a year earlier. That is a rise of four percentage points in a single year, and it interrupts a decline that had held since 2013-14, when the same figure stood at 64.2 per cent. In absolute terms, households paid close to INR 3.83 trillion directly for their healthcare in 2022-23, which amounts to roughly INR 2,767 per person in the country. 

Why the previous year looked so good

Before this is read as a sudden unravelling, it helps to understand why 2021-22 looked so unusually healthy. That was the peak of the Covid-19 pandemic response, when the government raised health spending to about 1.84 per cent of GDP to fund emergency care, oxygen, and the vaccination drive. Since the government was bearing so much of the cost that year, the households’ share fell to its lowest level on record. When that extraordinary spending wound down, the household share rose again. So, a meaningful part of the reversal is a return to the underlying trend rather than a fresh deterioration. The Health Ministry has been stressing that, over the full decade, the direction of travel remains downward, from 64.2 per cent to 43.4 per cent. That framing is fair. Yet it should not be allowed to close the conversation, because the household survey released a few weeks before the accounts tells the part of the story that the percentages alone cannot.

Coverage has grown, but protection has not followed

The National Statistical Office (NSO) conducted its 80th round survey on health through 2025, interviewing close to 1.4 lakh households across rural and urban India, and the picture it paints is one of genuine progress on access alongside a stubborn problem with cost. Insurance coverage has expanded remarkably since the previous such survey in 2017-18, more than tripling in rural areas and more than doubling in urban ones, so that close to half of all Indians, about 47 per cent of the rural population and 44 per cent of the urban population, now hold some form of health cover, most of it through government-financed schemes. Institutional deliveries have risen further, and more people are reporting ailments and seeking care, suggesting that awareness and willingness to engage with the system have both improved.

What has not kept pace is financial protection. The survey found the median out-of-pocket cost of a hospitalisation in 2025 to be about INR 11,285, and in public facilities, the median was as low as INR 1,100. The median, however, hides the households that the system fails most sharply, because the average cost of a hospitalisation, excluding childbirth, was far higher, at around INR 34,000 overall. That average is dragged upward by private hospitals, where the mean out-of-pocket cost of a hospital stay was roughly INR 50,500 compared with about INR 6,600 in a government hospital. Since most of India’s health spending still flows through private hospitals and pharmacies, a great many families are meeting the larger number rather than the smaller one.

The reason a family can hold an insurance card and still pay most of a bill lies in what the insurance does and does not cover. Schemes such as Ayushman Bharat, now extended to every citizen above seventy irrespective of income, are built around hospitalisation. They do comparatively little for the everyday spending on outpatient consultations, medicines, and tests that quietly accumulates over a year, and that everyday spending accounts for a large portion of household outlay. A cardholder admitted to an empanelled hospital may be well protected, while the same household, managing a chronic condition at home and buying medicines month after month, is hardly protected at all.

What the numbers cost in ordinary lives

The family in Tatanagar is far from unusual. Out-of-pocket health spending is rarely covered by a spare account set aside for that purpose. It comes from savings meant for other things, from borrowing at hard terms, and at times from selling land, gold, livestock or other productive assets, often at distressed prices. Several studies over the years have estimated that these payments push somewhere between three and seven per cent of Indian households below the poverty line each year, and that the burden falls heaviest on rural families and on the poorer states, precisely the households with the least to spare. When the share ticks up by four points, it is this population that feels it first.

There is also a target that hangs over all of this. The National Health Policy of 2017 committed to raising public health spending to 2.5 per cent of GDP by 2025. That year has now passed, and the latest official accounts put government health spending at 1.43 per cent of GDP in 2022-23. Much of the shortfall against that commitment has, in practice, been made up by households paying directly for their care.

Whether 2022-23 proves to be a single year of post-pandemic normalisation or the beginning of a longer stall will become clearer with the next set of accounts and with the coming Union Budget, both of which this series will follow closely. For now, the reversal is a useful reminder that the earlier progress was never automatic, and that a falling OOPE share depends on public spending continuing to rise. When that public spending steps back, the shortfall is absorbed by households like the one in Tatanagar, drawn from the savings and assets they can least afford to lose.


Comments

Popular posts from this blog

State of Women’s Health in India

The fifth National Family Health Survey 2019-21 (NFHS-5) conducted by the Ministry of Health and Family Welfare, Government of India, provides extensive insights on population, health and nutrition at the country and state/union territory level and even the estimates at the district level. The survey touches on over 130 parameters across 21 sub-categories, with some specific to women and children and others aimed at a broader population. It also provides a comparison of the performance of the urban and rural population. For the first time, the sex ratio of the total population (females per 1,000 males) crossed the four-figure mark. It stood at 1,020 females per 1,000 males vis-à-vis 991 in NFHS-4 conducted in 2015-16. This is a significant achievement and success of the government measures against the practice of female infanticide. A major contribution towards this achievement is the enactment of Pre-Natal Diagnostic Technique (PNDT) Act, 1994, which prohibits sex selection and the mi...

Mind the Gap

The Constitution of India states that it is the “ duty of the State to raise the level of nutrition and standard of living and to improve public health ” (Government of India, 1950) . However, for the past decade, the public health expenditure in India continues to hover around one per cent of the gross domestic product (GDP) (MoHFW, 2019) . According to the World Bank, India is a Lower Middle-Income country, but its spending on healthcare is even less than the countries in the Lower Income Group. Since government financing is a function of the taxes that it raises, countries with a higher tax to GDP ratio tends to have better-financed healthcare systems. Low and middle-income countries with not so robust tax to GDP ratio finds it difficult to meet the demand for financing the healthcare of its citizens completely. With a tax to GDP ratio falling to a decade low of 9.88 per cent in FY20 (Seth, 2020) , naturally, public financing in India is insufficient to meet the healthcare require...

PMJAY Revisited: The Cost of Treatment That Inflation Forgot

Replying to a question in the Rajya Sabha on 28 July 2026, the Minister of State for Health and Family Welfare, Prataprao Jadhav, informed Parliament that over 447.3 million Ayushman cards have now been generated under the Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (PMJAY), and that as of 30 June 2026, the scheme had authorised 126.9 million hospital admissions worth INR 1,920 billion. A post on this blog in December 2020 ( PMJAY: Average cost per treatment is 2.5 per cent of the sum assured ) ran a simple back-of-the-envelope calculation. At that time, the scheme had recorded about 14 million admissions worth INR 175 billion, averaging INR 12,500 per admitted patient. The question raised then was whether a scheme whose average claim was this modest really needed a headline cover of up to INR 500,000 per family per year. Five and a half years on, the same arithmetic is worth repeating. The average cost of treatment has increased from INR 12,500 to INR 15,130. On the face of it,...